E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells.

The steroid receptor coactivator oncogene, amplified in breast cancer 1 (AIB1; also known as ACTR/RAC-3/TRAM-1/SRC-3/p/CIP), is amplified and overexpressed in a variety of epithelial tumors. AIB1 has been reported to have roles in both steroid-dependent and steroid-independent transcription during tumor progression. In this report, we describe that the cellular levels of AIB1 are controlled through regulated proteasomal degradation. We found that serum withdrawal or growth in high cell density caused rapid degradation of AIB1 protein, but not mRNA, in immortalized cell lines. Proteasome inhibitors prevented this process, and high molecular weight ubiquitylated species of AIB1 were detected. Nuclear export was required for proteasomal degradation of AIB1 and involved the ubiquitin ligase, E6AP. AIB1/E6AP complexes were detected in cellular extracts, and reduction of cellular E6AP levels with E6AP short interfering RNA prevented proteasomal degradation of AIB1. Conversely, overexpression of E6AP promoted AIB1 degradation. The COOH terminus of AIB1 interacted with E6AP in vitro and deletion of this region in AIB1 rendered it resistant to degradation in cells. From our results, we propose a model whereby signals promoted by changes in the cellular milieu initiate E6AP-mediated proteasomal degradation of AIB1 and thus contribute to the control of steady-state levels of this protein.

[1]  B. O’Malley,et al.  The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation , 2000 .

[2]  A. Means,et al.  Peptidyl-Prolyl Isomerase 1 (Pin1) Serves as a Coactivator of Steroid Receptor by Regulating the Activity of Phosphorylated Steroid Receptor Coactivator 3 (SRC-3/AIB1) , 2005, Molecular and Cellular Biology.

[3]  Poonam K Sharma,et al.  Decreased expression of e6-associated protein in breast and prostate carcinomas. , 2005, Endocrinology.

[4]  Adrian V. Lee,et al.  AIB1/SRC-3 Deficiency Affects Insulin-Like Growth Factor I Signaling Pathway and Suppresses v-Ha-ras-induced Breast Cancer Initiation and Progression in Mice , 2004, Cancer Research.

[5]  A. Wellstein,et al.  A role for TGF-β in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells , 2002, Oncogene.

[6]  A. Schröder,et al.  The Transcriptional Co-activator p/CIP (NCoA-3) Is Up-regulated by STAT6 and Serves as a Positive Regulator of Transcriptional Activation by STAT6* , 2004, Journal of Biological Chemistry.

[7]  A Ciechanover,et al.  Activation of the heat-stable polypeptide of the ATP-dependent proteolytic system. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Maitra,et al.  Overexpression of the Nuclear Receptor Coactivator AIB1 (SRC-3) during Progression of Pancreatic Adenocarcinoma , 2004, Clinical Cancer Research.

[9]  J. Davie,et al.  Rapid Induction of Histone Hyperacetylation and Cellular Differentiation in Human Breast Tumor Cell Lines following Degradation of Histone Deacetylase-1* , 2000, The Journal of Biological Chemistry.

[10]  R. Hough,et al.  Ubiquitin-lysozyme conjugates. Identification and characterization of an ATP-dependent protease from rabbit reticulocyte lysates. , 1986, The Journal of biological chemistry.

[11]  N. Koibuchi,et al.  TRAM-1, A Novel 160-kDa Thyroid Hormone Receptor Activator Molecule, Exhibits Distinct Properties from Steroid Receptor Coactivator-1* , 1997, The Journal of Biological Chemistry.

[12]  E. Gehan,et al.  The Nuclear Receptor Coactivator AIB1 Mediates Insulin-like Growth Factor I-induced Phenotypic Changes in Human Breast Cancer Cells , 2004, Cancer Research.

[13]  W. Sellers,et al.  High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. , 2004, Cancer cell.

[14]  I. Fidler,et al.  In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. , 1999, Neoplasia.

[15]  A. Haas,et al.  The mechanism of ubiquitin activating enzyme. A kinetic and equilibrium analysis. , 1982, The Journal of biological chemistry.

[16]  J. Huibregtse,et al.  The Global Transcriptional Effects of the Human Papillomavirus E6 Protein in Cervical Carcinoma Cell Lines Are Mediated by the E6AP Ubiquitin Ligase , 2005, Journal of Virology.

[17]  J. Font de Mora,et al.  AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor , 2000, Molecular and Cellular Biology.

[18]  S. Hilsenbeck,et al.  Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. , 2003, Journal of the National Cancer Institute.

[19]  O. Hermanson,et al.  Regulation of somatic growth by the p160 coactivator p/CIP. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Meltzer,et al.  Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. , 1999, The American journal of pathology.

[21]  P. Howley,et al.  Identification of HHR23A as a Substrate for E6-associated Protein-mediated Ubiquitination* , 1999, The Journal of Biological Chemistry.

[22]  D. Neal,et al.  Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer , 2001, British Journal of Cancer.

[23]  P. Meltzer,et al.  AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. , 1997, Science.

[24]  Baljit Singh,et al.  Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue , 2001, Breast Cancer Research and Treatment.

[25]  C. Powers,et al.  Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells* , 2001, The Journal of Biological Chemistry.

[26]  M. Parker,et al.  Functional Interaction between the p160 Coactivator Proteins and the Transcriptional Enhancer Factor Family of Transcription Factors* , 2000, The Journal of Biological Chemistry.

[27]  W. Shao,et al.  Coactivator AIB1 links estrogen receptor transcriptional activity and stability. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. Baumeister,et al.  The proteasome: a macromolecular assembly designed for controlled proteolysis. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[29]  Hui Li,et al.  Differential Mechanisms of Nuclear Receptor Regulation by Receptor-associated Coactivator 3* , 2000, The Journal of Biological Chemistry.

[30]  Santhosh K. P. Kumar,et al.  Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Qin,et al.  Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. , 2004, Molecular cell.

[32]  A. Goldberg,et al.  Identity of the 19S 'prosome' particle with the large multifunctional protease complex of mammalian cells (the proteasome) , 1988, Nature.

[33]  R. Evans,et al.  Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.

[34]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[35]  J. P. Jensen,et al.  Subcellular Localization and Ubiquitin-conjugating Enzyme (E2) Interactions of Mammalian HECT Family Ubiquitin Protein Ligases* , 1997, The Journal of Biological Chemistry.

[36]  M. Yanagida,et al.  Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. , 1998, Experimental cell research.

[37]  J. Torchia,et al.  Microtubule-Dependent Subcellular Redistribution of the Transcriptional Coactivator p/CIP , 2002, Molecular and Cellular Biology.

[38]  D. Wazer,et al.  Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. , 2002, Cancer research.

[39]  J. Huibregtse,et al.  Human Scribble (Vartul) Is Targeted for Ubiquitin-Mediated Degradation by the High-Risk Papillomavirus E6 Proteins and the E6AP Ubiquitin-Protein Ligase , 2000, Molecular and Cellular Biology.

[40]  Yusuke Nakamura,et al.  Amplification and over‐expression of the AIB1 nuclear receptor co‐activator gene in primary gastric cancers , 2000, International journal of cancer.

[41]  J. Qin,et al.  Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator Activity by IκB Kinase , 2002, Molecular and Cellular Biology.

[42]  Hui Li,et al.  RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Z. Nawaz,et al.  Specific ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators. , 2003, Molecular endocrinology.

[44]  P. Howley,et al.  Human Papillomavirus Type 16 E6 Induces Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase , 2000, Journal of Virology.

[45]  M. Tsai,et al.  The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily , 1999, Molecular and Cellular Biology.

[46]  M. Yanagida,et al.  Molecular Cloning and Cell Cycle-dependent Expression of Mammalian CRM1, a Protein Involved in Nuclear Export of Proteins* , 1997, The Journal of Biological Chemistry.

[47]  M. Southey,et al.  Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. , 2001, Cancer research.

[48]  M. Tilli,et al.  Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice. , 2005, Molecular endocrinology.

[49]  A. Hershko,et al.  The protein substrate binding site of the ubiquitin-protein ligase system. , 1986, The Journal of biological chemistry.

[50]  P. Daniels,et al.  Molecular analysis of the interaction between HPV type 16 E6 and human E6‐associated protein , 1997, FEBS letters.

[51]  C. Lyttle,et al.  A Transcriptional Coactivator, Steroid Receptor Coactivator-3, Selectively Augments Steroid Receptor Transcriptional Activity* , 1998, The Journal of Biological Chemistry.